VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 35 filers reported holding VECTIVBIO HLDG AG in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,587 | -1.8% | 2,536,617 | 0.0% | 1.42% | -3.3% |
| Q4 2022 | $21,980 | -99.9% | 2,536,617 | 0.0% | 1.47% | +38.3% |
| Q3 2022 | $15,220,000 | -0.8% | 2,536,617 | -10.7% | 1.06% | -8.3% |
| Q2 2022 | $15,338,000 | +56.7% | 2,840,389 | +36.7% | 1.16% | +54.3% |
| Q1 2022 | $9,790,000 | -10.1% | 2,078,485 | -6.2% | 0.75% | +16.2% |
| Q4 2021 | $10,884,000 | -36.7% | 2,216,763 | -0.4% | 0.65% | -7.4% |
| Q3 2021 | $17,197,000 | -32.6% | 2,226,128 | 0.0% | 0.70% | -19.4% |
| Q2 2021 | $25,531,000 | – | 2,226,128 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,782,199 | $20,424,000 | 7.80% |
| CAXTON CORP | 194,577 | $1,051,000 | 1.41% |
| Cormorant Asset Management, LP | 2,840,389 | $15,338,000 | 1.16% |
| Novo Holdings A/S | 3,339,484 | $18,033,000 | 0.89% |
| Orbimed Advisors | 6,473,561 | $34,957,000 | 0.63% |
| Bpifrance SA | 2,806,217 | $15,154,000 | 0.57% |
| Eventide Asset Management | 2,339,044 | $12,631,000 | 0.27% |
| Tekla Capital Management LLC | 756,502 | $4,085,000 | 0.16% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 865,229 | $4,672,000 | 0.08% |
| Canaan Partners XI LLC | 37,051 | $200,000 | 0.07% |